Neuroprotective effect of the aminoestrogen prolame against impairment of learning and memory skills in rats injected with amyloid-β-25-35 into the hippocampus.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Pharmacology

• Publication date

  2012-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2012.04.020PMID 22542664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Local neuroinflammation and the progression of Alzheimer’s disease

  2011cited by this paper
• Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer’s disease

  2011cited by this paper
• Role of Neuronal Nitric-Oxide Synthase in Estrogen-Induced Relaxation in Rat Resistance Arteries

  2011cited by this paper
• The role of NOS in the impairment of spatial memory and damaged neurons in rats injected with amyloid beta 25-35 into the temporal cortex.

  2011influential reference
• The antithrombotic effect of the aminoestrogen prolame (N-(3-hydroxy-1,3,5(10)-estratrien-17B-YL)-3-hydroxypropylamine) is linked to an increase in nitric oxide production by platelets and endothelial cells.

  2010cited by this paper
• Hormonal Influences on Cognition and Risk for Alzheimer’s Disease

  2010cited by this paper
• The effects of 17beta-estradiol and vitamin E treatments on oxidative stress and antioxidant levels in brain cortex of diabetic ovariectomized rats.

  2010cited by this paper
• Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease.

  2010cited by this paper
• Action of estrogens in the aging brain: dementia and cognitive aging.

  2010cited by this paper
• Microglia and inflammation in Alzheimer's disease.

  2010cited by this paper
• Beta-estradiol reduces lipid peroxidation and depth of injury in cold-induced brain injury model.

  2010cited by this paper
• Effects of synaptic plasticity regulated by 17β-estradiol on learning and memory in rats with Alzheimer’s disease

  2010cited by this paper
• Neuroprotective effect of alpha-asarone on spatial memory and nitric oxide levels in rats injected with amyloid-beta((25-35)).

  2009influential reference
• Amyloid-β25–35 impairs memory and increases NO in the temporal cortex of rats

  2009influential reference
• Estrogen Stimulates Degradation of β-Amyloid Peptide by Up-regulating Neprilysin*

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Antioxidant effects of epicatechin on the hippocampal toxicity caused by amyloid-beta 25-35 in rats.

  2009cited by this paper
• Spatial Memory

  2008cited by this paper
• Nucleic acid oxidation in Alzheimer disease.

  2008cited by this paper
• Mitochondria in neuroplasticity and neurological disorders.

  2008cited by this paper
• Amyloid Precursor Protein Trafficking, Processing, and Function*

  2008cited by this paper
• Molecular basis of Alzheimer’s disease

  2007cited by this paper
• Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function

  2006cited by this paper
• β-Amyloid Degradation and Alzheimer's Disease

  2006cited by this paper
• Contrasting effects of estradiol and 17 beta-aminoestrogens on blood clotting time in rats and mice.

  2005cited by this paper
• Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers

  2005cited by this paper
• Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus

  2004cited by this paper
• Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

  2004cited by this paper
• Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats.

  2004cited by this paper
• Alzheimer's disease pathogenesis and therapeutic interventions.

  2004cited by this paper
• Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity.

  2004cited by this paper
• Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons.

  2004cited by this paper
• S-Allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits.

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• Equine Estrogens Differentially Prevent Neuronal Cell Death Induced by Glutamate

  2003cited by this paper
• Modulation of Aβ peptides by estrogen in mouse models

  2002cited by this paper
• Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

  2002cited by this paper
• Neuroprotection and neurodegenerative disease.

  2002cited by this paper
• Inflammation in neurodegenerative disease--a double-edged sword.

  2002cited by this paper
• The Search for an Amyloid Solution

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Aβ amyloidosis induces the initial stage of tau accumulation in APPSw mice

  2001cited by this paper
• The Neuroprotective Effects of Phytoestrogens on Amyloid β Protein-induced Toxicity Are Mediated by Abrogating the Activation of Caspase Cascade in Rat Cortical Neurons*

  2001cited by this paper
• Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal CA1 neurons in Alzheimer's disease and Pick's disease: a lesion distinct from granulovacuolar degeneration

  2001cited by this paper
• The neuropsychological diagnosis of Alzheimer's disease

  2001cited by this paper
• Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice.

  2001cited by this paper
• Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens.

  2000cited by this paper
• Oxidative processes in Alzheimer's disease: the role of Aβ-metal interactions

  2000cited by this paper
• Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions.

  2000cited by this paper
• Molecular basis of Alzheimer's disease

  2000cited by this paper
• Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein

  2000cited by this paper
• Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system

  1997cited by this paper
• In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat.

  1997cited by this paper
• In vitro aggregation facilitates β-amyloid peptide-(25–35)-induced amnesia in the rat

  1997cited by this paper
• Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system.

  1997cited by this paper
• Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines *

  1996cited by this paper
• Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

  1996cited by this paper
• Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.

  1995cited by this paper
• Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

  1995cited by this paper
• Age-related susceptibility to MPTP-induced neurotoxicity in mice.

  1993cited by this paper
• Comparative effect of synthetic aminoestrogens with estradiol on platelet aggregation.

  1993cited by this paper
• Amyloid and Alzheimer's disease--cause or effect?

  1989cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper
• Synthesis and molecular structure of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-3-hydroxypropylamine; an amino-estrogen with prolonged anticoagulant and brief estrogenic effects

  1985cited by this paper
• Synthesis and molecular structure of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-3-hydroxypropylamine; an amino-estrogen with prolonged anticoagulant and brief estrogenic effects.

  1985cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• The acoustics of the singing voice.

  1977cited by this paper
• Spatial memory.

  1977cited by this paper

• Effect of the aggregation state of amyloid-beta (25-35) on the brain oxidative stress in vivo

  2024cites this paper
• The pathomimetic oAβ25-35 model of Alzheimer's disease: Potential for screening of new therapeutic agents.

  2023cites this paper
• HIGH-CARBOHYDRATE AND FAT DIET CONSUMPTION CAUSES METABOLIC DETERIORATION, NEURONAL DAMAGE, AND LOSS OF RECOGNITION MEMORY IN RATS.

  2023cites this paper
• Swimming exercise and clove oil can improve memory by molecular responses modification and reduce dark cells in rat model of Alzheimer's disease.

  2023cites this paper
• Microwave-enhanced synthesis of 26-amino-22-oxocholestanes and their cytotoxic activity.

  2022cites this paper
• Amyloid-β (25-35) induces the morphological alteration of dendritic spines and decreases NR2B and PSD-95 expression in the hippocampus.

  2022cites this paper
• Betulinic acid attenuates cognitive dysfunction, oxidative stress, and inflammation in a model of T-2 toxin-induced brain damage

  2022cites this paper
• Phytotherapy: A promising approach for the treatment of Alzheimer's disease

  2021cites this paper
• Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause

  2021cites this paper
• Interplay of isoform 1N4R tau protein and amyloid-β peptide fragment 25-35 in reducing and non-reducing conditions.

  2020cites this paper
• Inhibitory mechanism of 17β-aminoestrogens in the formation of Aβ aggregates

  2019cites this paper
• Long‑term behavioral, histological, biochemical and hematological evaluations of amyloid beta‑induced Alzheimer's disease in rat.

  2018cites this paper
• Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation.

  2017cites this paper
• Green tea supplementation produces better neuroprotective effects than red and black tea in Alzheimer-like rat model.

  2017cites this paper
• The aminoestrogen prolame increases recognition memory and hippocampal neuronal spine density in aged mice

  2017cites this paper
• Antioxidative stress effect of epicatechin and catechin induced by Aβ25-35 in rats and use of the electrostatic potential and the Fukui function as a tool to elucidate specific sites of interaction.

  2016cites this paper
• Differential effect of the 17β-aminoestrogens prolame, butolame and pentolame in anxiety and depression models in rats.

  2016cites this paper
• In vivo and in vitro estrogenic profile of 17β-amino-1,3,5(10)estratrien-3-ol.

  2015cites this paper
• Evaluating the pathological and behavioural consequences of injecting amyloid beta oligomers in the rat

  2015cites this paper
• A high calorie diet causes memory loss, metabolic syndrome and oxidative stress into hippocampus and temporal cortex of rats

  2015influential citation
• 17β-Aminoestrogens induce guinea pig airway smooth muscle hyperresponsiveness through L-type Ca(2+) channels activation.

  2015cites this paper
• Colivelin ameliorates amyloid β peptide‐induced impairments in spatial memory, synaptic plasticity, and calcium homeostasis in rats

  2015cites this paper
• Study of the protective effects of nootropic agents against neuronal damage induced by amyloid-beta (fragment 25–35) in cultured hippocampal neurons

  2015cites this paper
• Memory Impairment in Estrogen Receptor α Knockout Mice Through Accumulation of Amyloid-β Peptides

  2014cites this paper
• Modeling Alzheimer's disease with non-transgenic rat models

  2013cites this paper